Michigan Pharmacists Association (MPA) encourages members to utilize the resources and links below to keep up-to-date on important pharmacy practice issues and regulations. Click on the bars below to view expanded content.
Continuous Quality Improvement
Continuous quality improvement (CQI) is an ongoing effort to improve products, services or processes. Starting a CQI program requires commitment, a culture of safety, policies, procedures and standardization; and a process for collection, analysis and improvement. The following resources will assist you with establishing a CQI program at your pharmacy or other practice site.
Drug Enforcement Administration
The Drug Enforcement Administration (DEA) is the premier drug enforcement organization in the world and the only single-mission federal agency dedicated to drug law enforcement. Follow the links below to access resources of value to pharmacists.
Provider Exclusion Lists
Federal regulations established by the Centers for Medicare and Medicaid Services (CMS) prohibit payment for any federal or state health care program services (prescriptions, durable medical equipment, labs, etc.) be made to any individuals or entities which are included on the Department of Health and Human Services Office of Inspector General (OIG) and General Services Administration (GSA) exclusions lists. Pharmacies and pharmacists must be aware of these regulations and ensure that all pharmacy personnel or contracted entities doing business with the pharmacy are not included on these exclusion lists to avoid payment recoupments as well as possible loss in the ability to participate in state or federal programs, including Medicare and Medicaid. Recent information provided by OIG is recommending that the provider exclusion lists be checked monthly since new data of excluded parties is added to these lists.
In addition to the OIG/GSA exclusion lists, providers also need to review the Data Bank to check for excluded individuals. The Data Bank is a clearinghouse created by Congress, which is comprised of the National Practitioner Data Bank and the Healthcare Integrity and Protection Data Bank. The Data Bank contains received and disclosed information on final actions taken against health care providers and entities. Access each of the lists at the links below.
U.S. Food and Drug Administration
The U.S. Food and Drug Administration (FDA) is responsible for protecting and promoting public health through the regulation and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter medications, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED) and veterinary products. Visit www.FDA.gov for additional information or follow the links below to access additional resources.
National Council on Patient Information and Education
The NCPIE Coalition offers resources focused on raising awareness about the role of communication in promoting safe, appropriate use of medications. A variety of research articles, recommendations for improving adherence geared toward specific types of health care providers and information on NCPIE initiative are available online.
Script Your Future
The tools provided on this Web site help patients keep track of their medications, including a wallet card, question builder, how-to videos about taking medications, and tips to assist them in talking with their pharmacist or physician about a health problem or medication.
Stick to the Script
This online resource center provides pharmacists and other health care professionals with tools and information to improve medication adherence. Adherence programs around the nation are identified, clinical tools are provided; research, education and outreach concepts and resources are addressed; and information about building an adherence toolkit is also shared. Below are some additional links on the Stick to the Script Web site that are valuable for pharmacy professionals.
Alliance for Patient Medication Safety
The Alliance for Patient Medication Safety (APMS) strives to foster a culture of quality within the profession of pharmacy that promotes a continuous systems analysis to develop best practices that will reduce medication errors,
improve medication use and enhance patient care. To learn more go
Institute for Patient Medication Safety and Pharmacist Peer Review
MPA, the Michigan Board of Pharmacy and the Michigan Bureau of Health Professions worked together to design a system that encourages voluntary pharmacist reporting of medication errors and their causes so data can be accumulated and analyzed and information disseminated to practitioners to help prevent errors of a similar nature in the future. This also provides the Board of Pharmacy with a way to move away from a punitive approach in dealing with pharmacists who make human errors.
MPA created the Institute for Patient Medication Safety and Pharmacist Peer Review, an organization that collects information on medication errors, while protecting the pharmacists who report them. No information regarding the identity of the patient or the pharmacist is retained in Institute files after an error has been reported.
Although MPA provided the initial funding, the Institute has been established as a Michigan nonprofit corporation and is classified by the IRS as a 501(c)(3) tax-exempt organization. Its operation is overseen by a seven-member Board of Directors. Each director is a pharmacist who brings expertise from a specific area of pharmacy practice (health-system, community, long-term care, etc.) Last month, MPA and the Institute sent a letter to all licensed pharmacists in the state providing them with an overview of the organization, as well as frequently asked questions and a medication error or accident reporting form. Additional copies of the form can be downloaded from the Institute Web site at MiInstitute.cphs.wayne.edu.
Medication Therapy Management
Medication therapy management (MTM) utilizes pharmacists knowledge-based and clinical skills to improve medication usage in patient care. MTM services vary based on practice area and can include formulary management, complex disease state management and medication therapy.
MTM was validated by its inclusion in the final regulations under the Medicare Modernization Act (MMA) of 2003 in addition to the creation of Medicare prescription drug benefit. While Medicare Part D plans are required to provide MTM services to beneficiaries who meet certain requirements, many other individuals can benefit from MTM programs.
MTM provides an excellent opportunity for pharmacists to make the most of their clinical expertise and in the process, help patients. It is now possible for pharmacists to be reimbursed for some of the services they have been providing for years.
Michigan Administrative Code
The Michigan Administrative Code is a compilation of all adopted rules and regulations that are in effect in the State of Michigan. Click here to view the Department of Community Health rules.
Michigan Automated Prescription System
The Michigan Automated Prescription System (MAPS) is the prescription monitoring program for the state of Michigan. Prescription monitoring programs are used to identify and prevent drug diversion at the prescriber, pharmacy and patient levels by collecting Schedule 2-5 controlled substances prescriptions dispensed by pharmacies and practitioners. Follow the links below to register to MAPS online or access important instructions. Or, visit the MAPS Web site for addtional information.
Michigan Board of Pharmacy
The Michigan Board of Pharmacy consists of 11 voting members: six pharmacists and five public members. As of Oct. 1, 2012, the Board oversees 14,734 pharmacists, 3,257 pharmacies and 1,742 manufacturer/wholesalers.
The Public Health Code, by Section 17722, grants authority to the Board of Pharmacy to regulate, control and inspect the character and standards of pharmacy practice and of drugs manufactured, distributed, prescribed, dispensed and administered or issued in this State and procure samples, and limit or prevent the sale of drugs that do not comply with this section's provisions; prescribe minimum criteria for the use of professional and technical equipment in reference to the compounding and dispensing of drugs; grant pharmacy licenses for each separate place of practice of a dispensing prescriber who meets requirements for drug control licensing; and granting licenses to manufacturer/wholesaler distributors of prescription drugs. The Board also has the obligation to discipline licensees who have adversely affected the public's health, safety and welfare.
Visit the Michigan Board of Pharmacy Web site to learn more about its role, current members and meeting days and locations.
Michigan Department of Licensing and Regulatory Affairs
The Health Professions Division in the Bureau of Health Care Services, in conjunction with state licensing boards, regulates more than 400,000 health professionals in Michigan who are licensed, registered or certified under Articles 7 and 15 of the Michigan Public Health Code and pharmacy related facilities. Utilize the links below to access important pharmacist licensure information online.
Michigan Public Health Code
View the Michigan Public Health Code online.
Pay particular attention to the following sections:
Other areas of the Public Health Code that impact prescribing:
Combat Methamphetamine Epidemic Act 2005
National Precursor Log Exchange
The National Precursor Log Exchange (NPLEx) is a real-time electronic logging system used by pharmacies, retailers and law enforcement to track sales of over-the-counter (OTC) cold and allergy medications containing precursors to the illegal drug methamphetamine.
As of Jan. 1, 2012, in compliance with Public Act 86 of 2011, pharmacies are required to log pseudoephedrine (PSE) product sales in the NPLEx system. The provider of the NPLEx technology, Appriss, shared several resources with MPA that will assist members in utilizing the system, including a deployment guide and a complete NPLEx overview. If you have any questions, please contact Appriss by e-mail at MINPLEx@appriss.com. Be sure to include your pharmacy contact information and state license number.
Pharmacies are also required to maintain a logbook, written or electronic, to record sales of products containing ephedrine, pseudoephedrine or phenylpropanolamine. The seller must enter into the logbook the name of the product and quantity sold. The patient must write or enter into the logbook their name, address, date and time of sale. The customer must also sign the logbook.
Pharmacies with a point-of-sale (POS) system integrated to NPLEx that will electronically capture and submit purchaser, product and signature data do not need to utilize a manual logbook unless there is a mechanical or electronic failure with the electronic sales tracking system and the pharmacy is unable to comply with the electronic sales tracking requirement.
Pharmacies without the ability to electronically capture all the required elements (purchaser, product and signature) must maintain a manual logbook.
Pharmacy Services Inc. (PSI), a for-profit subsidiary of MPA, offers several products to assist you with remaining in compliance with federal and state regulations, including a pseudoephedrine logbook. Click here to access an order form.
Discrepancy Reporting Form
This form was developed as a tool for pharmacies to report third party payment discrepancies. MPA requests that the form be submitted to MPA, as well as the third party payor, so these discrepancies may be recorded.
Price Discrepancy Complaint Form
This form was developed for the purpose of filing a complaint about incorrect information on the Department of Community Health Drug Pricing Web site.